Dr. J. VANSLEMBROUCK

Active

Private limited companyfounded 2006active for 20 yearsWortegemstraat 104B, 9700 Oudenaarde, BelgiumKBO/BCE: BE 0884.741.552

From the official registers: KBO 18 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. J. VANSLEMBROUCK has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €632,344 and a net result of €95,142. Equity is growing by about 6% per year across the filed financial years. Its solvency ranks better than 55% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

Dr. J. VANSLEMBROUCKActiveChecked score 93/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 24-10-2006 Normal situation
Legal form: Private limited company
Registered office: Wortegemstraat 104B, 9700 Oudenaarde
Activity: Specialist medical practice NACE 86220and 1 other
Establishment unit: 2.180.507.441 9700 Oudenaarde, since 24-10-2006
Financial year end: 30 June
Peppol: Reachable since 01-03-2026

Company details

Who decides

Board

VANSLEMBROUCK JürgenDirector · since 03-11-2006

Holdings: Shares in 1 company Open MRI Zen B.V.

Board & ownership

How it is doing

93 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts to 30-06-2025

Gross margin: €288,869; ▲ 6.2%
Turnover: ≈ €450,000; estimated
Profit: €95,142; ▼ 1.2%
Equity: €632,344; ▼ 9.4%
Total assets: €922,535; ▼ 12.7%
Staff: 1 FTE; =

2025 accounts filed 2 days late

Filed on 02-02-2026PDF

Financials

Why 93lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.09, cash €243,717Size: total assets €922,535Figures for financial year 2025 (filed 05-02-2026)Show the evidence

Checked score

Score 2025

93 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 44% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 94+3

equity 68.5% of total assets

Liquidity 83-7

short-term debt 9.0% · cash 26.4%

Profitability 82+2

return on assets 10.3%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026highest value 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €55,000 on 30-day terms is acceptable

Liquidity ample (current ratio 6.09, compared with 8.39 in 2024, above the usual 1.5; short-term debt: 9% and cash: 26.4% of total assets), and 31.5% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 56% on solvency, 66% on liquidity, 29% on profitability and 27% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises risk

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 6.09, cash €243,717

NBB · annual accounts

Size: total assets €922,535

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Figures for financial year 2025 (filed 05-02-2026)

NBB · annual accounts

2025 accounts filed 2 days late

The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 02-02-2026, 2 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 10 filings

Deviation from the deadline

2025

2 days late

2024

5 days late

2023

2 days early

2022

6 days late

2021

on the day

2020

3 days early

2019

4 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 1 day after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 2 February (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-06-2026 year end01-11-2026 today31-01-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Among the best 14% on equitysector median €124,628 · 20,680 companies €632,344 View
Positive: 7 profitable years in a rowprofit 2025: €95,142 7 years View

Documents

Key facts about Dr. J. VANSLEMBROUCK

What is the company number of Dr. J. VANSLEMBROUCK?: 0884.741.552. In Belgium the VAT number is the company number with BE in front: BE 0884.741.552.
Where is Dr. J. VANSLEMBROUCK based?: The registered office is at Wortegemstraat 104B, 9700 Oudenaarde.Company details
What does Dr. J. VANSLEMBROUCK do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. J. VANSLEMBROUCK?: Private limited company (BV).
When was Dr. J. VANSLEMBROUCK founded?: On 24-10-2006.
Is Dr. J. VANSLEMBROUCK still active?: Yes, Dr. J. VANSLEMBROUCK is an active enterprise in the KBO register.
How many employees does Dr. J. VANSLEMBROUCK have?: On average 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Dr. J. VANSLEMBROUCK?: ≈ €450,000 in financial year 2025. Estimated from the gross margin of €288,869: probably between €400,000 and €560,000, based on 36 comparable companies, NACE 862.
Is Dr. J. VANSLEMBROUCK profitable?: In financial year 2025, Dr. J. VANSLEMBROUCK made a profit of €95,142.
Where can I find the annual accounts of Dr. J. VANSLEMBROUCK?: Dr. J. VANSLEMBROUCK filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Dr. J. VANSLEMBROUCK due?: By 31-01-2027, for financial year 2026.Timeline